<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T01:35:54Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/13146" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/13146</identifier><datestamp>2026-10-18T20:33:41Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>The CHA2DS2-VASc Score and Acute Stent Thrombosis After Primary Percutaneous Coronary Intervention</dc:title><dc:creator>Degirmenci, Husnu</dc:creator><dc:creator>Bakirci, Eftal Murat</dc:creator><dc:subject>Humans</dc:subject><dc:subject>Percutaneous Coronary Intervention</dc:subject><dc:subject>Stents</dc:subject><dc:subject>Thrombosis</dc:subject><dc:subject>creatine kinase</dc:subject><dc:subject>magnesium</dc:subject><dc:subject>triacylglycerol</dc:subject><dc:subject>acute stent thrombosis</dc:subject><dc:subject>cerebrovascular accident</dc:subject><dc:subject>CHA2DS2-VASc score</dc:subject><dc:subject>coronary angiography</dc:subject><dc:subject>diabetes mellitus</dc:subject><dc:subject>human</dc:subject><dc:subject>hypertension</dc:subject><dc:subject>Letter</dc:subject><dc:subject>magnesium blood level</dc:subject><dc:subject>multivariate analysis</dc:subject><dc:subject>peripheral occlusive artery disease</dc:subject><dc:subject>platelet count</dc:subject><dc:subject>product parameters</dc:subject><dc:subject>sample size</dc:subject><dc:subject>ST segment elevation myocardial infarction</dc:subject><dc:subject>stent diameter</dc:subject><dc:subject>stent length</dc:subject><dc:subject>stent thrombosis</dc:subject><dc:subject>triacylglycerol blood level</dc:subject><dc:subject>adverse device effect</dc:subject><dc:subject>adverse event</dc:subject><dc:subject>stent</dc:subject><dc:publisher>SAGE Publications Inc.</dc:publisher><dc:date>2021</dc:date><dc:type>Letter</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/13146</dc:identifier><dc:identifier>https://doi.org/10.1177/0003319720985635</dc:identifier><dc:identifier>0003-3197</dc:identifier><dc:language>en</dc:language><dc:relation>Angiology</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/13146</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>